Vicarious Surgical
RBOT
RBOT was delisted on the 2nd of March, 2026.
72 hedge funds and large institutions have $18.9M invested in Vicarious Surgical in 2024 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 19 reducing their positions, and 10 closing their positions.
0% more funds holding
Funds holding: 72 → 72 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 10
0% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 19
0.06% less ownership
Funds ownership: 1.4% → 1.34% (-0.06%)
21% less capital invested
Capital invested by funds: $23.9M → $18.9M (-$5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$206K |
| 2 |
DP
DDD Partners
Bellevue,
Washington
|
+$107K |
| 3 |
DnB Asset Management
Oslo,
Norway
|
+$105K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$70.6K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$36.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAMHA
MY.Alpha Management HK Advisors
Hong Kong
|
-$462K |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$345K |
| 3 |
Renaissance Technologies
New York
|
-$197K |
| 4 |
Morgan Stanley
New York
|
-$187K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$82.5K |
RBOT Hedge Fund Activity: Q1 2024 in Review
72 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Vicarious Surgical (RBOT) for Q1 2024, worth a combined $18.9M — down 21% from $23.9M a quarter earlier.
Fund positioning in RBOT was balanced in Q1 2024: 10 funds opened new positions, 10 closed out, 19 added to existing stakes and 19 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $206K. The largest seller was MY.Alpha Management HK Advisors, cutting an estimated $462K.
- 72 institutional investors held Vicarious Surgical (RBOT) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $18.9M of Vicarious Surgical stock for Q1 2024, down 21% quarter-over-quarter.
- 10 funds opened new Vicarious Surgical positions in Q1 2024 and 10 closed out, a net change of 0 holders.
- The largest Vicarious Surgical buyer in Q1 2024 was Geode Capital Management, an estimated $206K added.
- The largest Vicarious Surgical seller in Q1 2024 was MY.Alpha Management HK Advisors, an estimated $462K sold.
Based on aggregated 13F filings for Q1 2024.